Prothena Corporation plc (PRTA) vs YD Bio Limited (YDES)

Prothena Corporation plc PRTA 8.38 +2.07%
YD Bio Limited YDES 6.98 +9.06%

Prothena Corporation plc and YD Bio Limited are both Biotechnology companies. Prothena Corporation plc and YD Bio Limited are of similar size ($453.0M and $421.5M).

Metric	PRTA	YDES	Biotechnology median
P/E	n/m	—	10.64
P/S	7.89	—	9.59
P/B	1.50	—	2.15
Price to free cash flow	n/m	—	26.07
EV/EBITDA	n/m	—	0.65
EV/Sales	2.60	—	9.45
Earnings yield	(10.06%)	—	(34.69%)
Free cash flow yield	(14.13%)	—	(24.02%)

Metric	PRTA	YDES	Biotechnology median
Gross margin	100.00%	—	65.59%
Operating margin	(101.80%)	—	0.00%
Net margin	(80.67%)	—	0.00%
Free cash flow margin	(111.49%)	—	0.00%
Return on equity	(14.39%)	—	(51.96%)
Return on assets	(12.54%)	—	(46.06%)
Return on invested capital	0.00%	—	0.00%

Metric	PRTA	YDES	Biotechnology median
Revenue growth (TTM)	427.32%	—	4.59%
EPS growth (last fiscal year)	(99.56%)	—	29.88%
Revenue growth, 5-year CAGR	62.56%	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	PRTA	YDES	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	25.05	—	4.86
Net debt to EBITDA	1.46	—	1.01

Metric	PRTA	YDES	Biotechnology median
Dividend yield	—	—	0.38%
Payout ratio	—	—	—

Metric	PRTA	YDES	Biotechnology median
Market cap	421.47m	453.04m	174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack